Carmot Therapeutics
Latest round
- Series E
Last raised
- May 2023
Total raised
- $367M
Investors
- 14
About Carmot Therapeutics
Carmot Therapeutics, Inc.Founded in 2008 and headquartered in Berkeley, US, Carmot Therapeutics, Inc. specializes in drug discovery and development. The company was established by Stig Hansen and has undergone significant transformations in its operational strategies. The company has engaged in 11 deals, with the most recent deal occurring on December 3, 2023.Carmot Therapeutics focuses on advancing drug discovery through its innovative platform that leverages unique screening technologies. Their services aim to identify and optimize small molecules for various therapeutic targets, providing solutions that facilitate the development of novel pharmaceuticals.Looking ahead, Carmot Therapeutics plans to leverage the recent acquisition by F. Hoffmann-La Roche Ltd to enhance its research and development capabilities. The acquisition is intended to strengthen Roche's portfolio in cardiovascular and metabolic diseases, with an additional USD 400 mn available upon achieving specific milestones. This strategic move is anticipated to expand Carmot's reach in new markets, particularly in North America and Europe, as it continues to develop clinical-stage incretin programs.
Who invested in Carmot Therapeutics
14 investors across 7 rounds
See all investors in Carmot Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
May 24, 2023
Amount
$152M
Investors
Series D
Jul 25, 2022
Amount
$161M
Investors
Series C
Sep 17, 2020
Amount
$26M
Investors
Series B
Jan 17, 2018
Amount
$15M
Investors
Series B
Aug 11, 2017
Amount
$11M
Investors
Series A
Jul 17, 2012
Amount
$0.5M
Investors
Series A
Apr 12, 2010
Amount
$1.6M
Investors
Questions about Carmot Therapeutics
Who invested in Carmot Therapeutics?
Carmot Therapeutics has 14 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Carmot Therapeutics raised?
Carmot Therapeutics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Carmot Therapeutics last raise money?
Carmot Therapeutics's most recent round on record is a Series E, in May 2023.
What does Carmot Therapeutics do?
Carmot Therapeutics is a biotechnology company.
Where is Carmot Therapeutics headquartered?
Carmot Therapeutics is headquartered in Berkeley, US.
Which VCs invest in companies like Carmot Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Carmot Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Carmot Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.